Stock Evaluator: Senseonics Holdings, Inc. (SENS)

Senseonics Holdings, Inc. SENS

$9.94 0.56 5.97%
September 2, 2026 4:00:00 PM EST November 10, 2021 Volume: 820,504
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Commentary & Analysis


Financial Summary

Share Statistics SENS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $496.0 $405.9 37%
Shares Out (Mil) 57.8 41.6 51%
Institutional Ownership 79.5% 83.1% 48%
Float (Mil) 44.3 35.6 44%
Beta 0.97 0.88 58%
Avg Daily Volume (000s) 668 337 64%
Price Change
(52-week)
2.1% 65.0% 49%
Growth SENS Industry
Median
Percentile
(All Stocks)
Sales (5yr) 48.4% 11.8% 95%
Net Income (5yr) 17.0% (5.9%) 68%
EPS (5yr) 36.0% 10.2% 86
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 34.5% (15.6%) 88%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 6 6 6
Current EPS ($0.532) ($2.293) ($1.947)
Month Ago EPS ($0.602) ($2.450) ($2.192)
# Rev Up 1 2 1
# Rev Down 0 0 0
Three Months Ago EPS ($0.602) ($2.450) ($2.192)
Year/Year Chg (16.2%) 38.1% (10.2%)
Financials SENS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $49 $119 19%
Net Income (TTM) (Mil) ($109) ($9) 10%
EPS (TTM) ($2.254) ($0.400) 13%
Operating Cash Flow (TTM) (Mil) ($96) ($3) 6%
Net Cash Flow (TTM) (Mil) $13 $1 59%
Long-Term Debt (Q1) (Mil) $62 $22 41%
Enterprise Value (Q1) (Mil) $434 $371 33%
Valuation SENS Industry
Median
Percentile
(All Stocks)
P/B 5.49 3.04 81%
P/E na 27.4 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.6 na
Ratios SENS Industry
Median
Percentile
(All Stocks)
Gross Margin 54.9% 58.5% 67%
Net Margin (225.3%) (6.9%) 4%
ROA (66.9%) (13.1%) 9%
ROE (118.2%) (13.1%) 8%
Liabilities to Assets 48.9% 46.1% 41%
F-Score 3 4 18%

Passing Stock Screens

As of 9/1/2026, from a list of 60 stock screening strategies, SENS meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors